Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial

This publication has 16 references indexed in Scilit:

• International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases
  Clinical Infectious Diseases, 2011
• Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study
  The Lancet Infectious Diseases, 2010
• Prospective cohort study of acute pyelonephritis in adults: Safety of triage towards home based oral antimicrobial treatment
  Journal of Infection, 2010
• Has the era of untreatable infections arrived?
  Journal of Antimicrobial Chemotherapy, 2009
• The Maxwell Finland Lecture: For the Duration-- Rational Antibiotic Administration in an Era of Antimicrobial Resistance and Clostridium difficile
  Clinical Infectious Diseases, 2008
• Non‐inferiority trials: design concepts and issues – the encounters of academic consultants in statistics
  Statistics in Medicine, 2002
• Comparison of Ciprofloxacin (7 Days) and Trimethoprim-Sulfamethoxazole (14 Days) for Acute Uncomplicated Pyelonephritis in Women
  JAMA, 2000
• Aminoglycosides do not Improve the Efficacy of Cephalosporins for Treatment of Acute Pyelonephritis in Women
  Scandinavian Journal of Infectious Diseases, 1997
• Randomised double-blind study of norfloxacin and cefadroxil in the treatment of acute pyelonephritis
  European Journal of Clinical Microbiology & Infectious Diseases, 1990
• Acute Renal Infection in Women: Treatment with Trimethoprim-Sulfamethoxazole or Ampicillin for Two or Six Weeks
  Annals of Internal Medicine, 1987